Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations

This publication has 53 references indexed in Scilit:

• Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues?
  Cell Communication and Signaling, 2013
• Wnt/β-Catenin Signaling and Disease
  Cell, 2012
• Proteomic analysis of β‐catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway
  Proteomics, 2009
• Unique phenotype of hepatocellular cancers with exon‐3 mutations in beta‐catenin gene†
  Hepatology, 2009
• Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced Hepatocarcinogenesis
  Cancer Research, 2008
• Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
  Gastroenterology, 2008
• Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
  Journal of Hepatology, 2008
• Distinct pathways of genomic progression to benign and malignant tumors of the liver
  Proceedings of the National Academy of Sciences, 2007
• Liver‐specific loss of β‐catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice†‡
  Hepatology, 2006
• Upstream and downstream of mTOR
  Genes & Development, 2004